At the time of writing, Spruce Biosciences Inc [SPRB] stock is trading at $0.43, up 3.43%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SPRB shares have gain 3.58% over the last week, with a monthly amount glided 13.72%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Spruce Biosciences Inc [NASDAQ: SPRB] stock has seen the most recent analyst activity on December 11, 2024, when Oppenheimer downgraded its rating to a Perform. Previously, JMP Securities downgraded its rating to Mkt Perform on December 11, 2024. On March 14, 2024, downgrade downgraded it’s rating to Sector Perform and revised its price target to $2 on the stock. Leerink Partners downgraded its rating to a Market Perform and decreased its price target to $2 on March 14, 2024. Ladenburg Thalmann downgraded its rating to a Neutral. H.C. Wainwright downgraded its rating to Neutral for this stock on March 14, 2024. In a note dated March 14, 2024, Guggenheim downgraded an Neutral rating on this stock.
For the past year, the stock price of Spruce Biosciences Inc fluctuated between $0.34 and $5.95. Spruce Biosciences Inc [NASDAQ: SPRB] shares were valued at $0.43 at the most recent close of the market.
Analyzing the SPRB fundamentals
According to Spruce Biosciences Inc [NASDAQ:SPRB], the company’s sales were 7.10M for trailing twelve months, which represents an -80.41% plunge. Gross Profit Margin for this corporation currently stands at -0.14% with Operating Profit Margin at -6.09%, Pretax Profit Margin comes in at -5.55%, and Net Profit Margin reading is -5.55%. To continue investigating profitability, this company’s Return on Assets is posted at -0.61, Equity is -0.62 and Total Capital is -0.81. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4118 points at the first support level, and at 0.3985 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4370, and for the 2nd resistance point, it is at 0.4489.
Ratios To Look Out For
It is important to note that Spruce Biosciences Inc [NASDAQ:SPRB] has a current ratio of 5.36. As well, the Quick Ratio is 5.36, while the Cash Ratio is 5.06. Considering the valuation of this stock, the price to sales ratio is 2.47, the price to book ratio is 0.34.
Transactions by insiders
Recent insider trading involved Novo Holdings A/S, 10% Owner, that happened on Mar 21 ’24 when 0.47 million shares were sold. 10% Owner, Novo Holdings A/S completed a deal on Mar 18 ’24 to sell 0.84 million shares. Meanwhile, 10% Owner Novo Holdings A/S sold 0.59 million shares on Mar 19 ’24.
